Physician profile
Thomas E Macgillivray
NPI 1184605354
$11,209.20
in general payments reported to CMS, 2019-2025
29 companies · $1,142 in 2025
The $1,142 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,087 · 2020: $941 · 2021: $1,870 · 2022: $2,472 · 2023: $1,151 · 2024: $1,546 · 2025: $1,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,655 · Travel and Lodging: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,654.66 |
| Travel and Lodging | $183.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,590.51 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Epic, Triclip |
| Abiomed | $1,581.88 | 2019-2024 | Impella |
| Medtronic, INC. | $1,487.56 | 2021-2025 | Avalus, Corevalve Evolut R, Symplicity G3 |
| Baxter Healthcare | $708.00 | 2019-2022 | |
| Edwards Lifesciences Corporation | $540.62 | 2020-2023 | |
| Livanova USA, INC. | $476.90 | 2019-2020 | |
| Atricure, INC. | $475.92 | 2021-2025 | Synergy Ablation System |
| W. L. Gore & Associates, INC. | $450.69 | 2019-2022 | |
| Angiodynamics, INC. | $318.04 | 2022-2024 | Angiovac |
| Cook Medical LLC | $310.17 | 2019-2024 | Zenith |
| Bolton Medical INC | $306.32 | 2020-2024 | Treo Abdominal Stent-Graft System |
| Zimmer Biomet Holdings, INC. | $267.99 | 2019-2021 | |
| Medtronic Vascular, INC. | $259.24 | 2019-2020 | |
| Boston Scientific Corporation | $249.41 | 2019-2023 | Watchman Access System |
| Corcym INC | $224.67 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $210.05 | 2019-2022 | |
| Biom'Up France Sas | $166.48 | 2021 | |
| Artivion, INC. | $159.74 | 2025 | Amds-Ascyrus Medical |
| Cerus Corporation | $119.00 | 2024 | Intercept Blood System For Platelets |
| Ethicon US, LLC | $74.71 | 2019-2024 | Evarrest, Vistaseal, Stratafix |
| Astrazeneca Pharmaceuticals LP | $72.83 | 2022 | |
| Kls-Martin L.P. | $42.04 | 2021 | |
| Pfizer INC. | $33.37 | 2020-2021 | |
| Biom'Up Sa | $19.92 | 2019 | |
| Amgen INC. | $17.55 | 2019 | |
| Sanara Medtech INC. | $17.30 | 2021 | |
| Acell, INC. | $15.33 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.96 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Macgillivray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.